Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07405177 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of MK-7240 in Healthy Participants (MK-7240-009)

StatusCompleted
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Lead sponsor: Merck Sharp & Dohme LLC to Merck Sharp & Dohme LLC Trial completed · Primary completion date changed from estimate of Sep 3, 2026 to Sep 15, 2026 · Study completion date changed from estimate of Sep 3, 2026 to Sep 19, 2026 · 2 more Show 5 more changesShow less
    • Trial completed
    • Primary completion date changed from estimate of Sep 3, 2026 to Sep 15, 2026
    • Study completion date changed from estimate of Sep 3, 2026 to Sep 19, 2026
    • Secondary endpoints: details revised at 4 of 9 entries
    • Eligibility criteria expanded, about 3 words
  2. Trial status changed: Recruiting → Active, Not Recruiting Site details revised at 2 of 2 sitesv5 Show 1 more changeShow less
    • Site details revised at 2 of 2 sites
  3. Re-verified, no change to tracked fieldsv4
  4. Study sites: 1 to 2v3
  5. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Study title expanded, about 1 wordv2 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Study title expanded, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Merck (MSD)
407 trials monitored
See 29 trials at risk
The goal of this study is to learn what happens to MK-7240 in a healthy person's body over time (pharmacokinetic or PK study). Researchers also want to learn about the safety of MK-7240 and if people tolerate it.
Trial Details
NCT Number NCT07405177
Lead Sponsor Merck Sharp & Dohme LLC
Conditions Healthy
Enrollment 330 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov